These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27357074)

  • 21. The effect of engaging unpaid informal providers on case detection and treatment initiation rates for TB and HIV in rural Malawi (Triage Plus): A cluster randomised health system intervention trial.
    Bello G; Faragher B; Sanudi L; Namakhoma I; Banda H; Malmborg R; Thomson R; Squire SB
    PLoS One; 2017; 12(9):e0183312. PubMed ID: 28877245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial.
    McNairy ML; Lamb MR; Gachuhi AB; Nuwagaba-Biribonwoha H; Burke S; Mazibuko S; Okello V; Ehrenkranz P; Sahabo R; El-Sadr WM
    PLoS Med; 2017 Nov; 14(11):e1002420. PubMed ID: 29112963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy.
    Kredo T; Adeniyi FB; Bateganya M; Pienaar ED
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD007331. PubMed ID: 24980859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varying intervals of antiretroviral medication dispensing to improve outcomes for HIV patients (The INTERVAL Study): study protocol for a randomized controlled trial.
    Hoffman R; Bardon A; Rosen S; Fox M; Kalua T; Xulu T; Taylor A; Sanne I
    Trials; 2017 Oct; 18(1):476. PubMed ID: 29029644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality in HIV and tuberculosis patients following implementation of integrated HIV-TB treatment: Results from an open-label cluster-randomized trial.
    Naidoo K; Gengiah S; Yende-Zuma N; Mlobeli R; Ngozo J; Memela N; Padayatchi N; Barker P; Nunn A; Karim SSA
    EClinicalMedicine; 2022 Feb; 44():101298. PubMed ID: 35198922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE II): protocol for a randomized evaluation.
    Rosen S; Maskew M; Brennan AT; Fox MP; Vezi L; Ehrenkranz PD; Venter WDF
    Trials; 2018 Oct; 19(1):548. PubMed ID: 30305142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.
    Herce ME; Morse J; Luhanga D; Harris J; Smith HJ; Besa S; Samungole G; Kancheya N; Muyoyeta M; Reid SE
    BMC Infect Dis; 2018 Oct; 18(1):536. PubMed ID: 30367622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cluster-randomized controlled trial to improve the quality of integrated HIV-tuberculosis services in primary healthcareclinics in South Africa.
    Gengiah S; Barker PM; Yende-Zuma N; Mbatha M; Naidoo S; Taylor M; Loveday M; Mhlongo M; Jackson C; Nunn AJ; Padayatchi N; Karim SSA; Naidoo K
    J Int AIDS Soc; 2021 Sep; 24(9):e25803. PubMed ID: 34498370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving child tuberculosis contact identification and screening in Lesotho: Results from a mixed-methods cluster-randomized implementation science study.
    Hirsch-Moverman Y; Howard AA; Mantell JE; Lebelo L; Frederix K; Wills A; Hesseling AC; Nachman S; Maama LB; El-Sadr WM
    PLoS One; 2021; 16(5):e0248516. PubMed ID: 34014956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depressive symptoms and hazardous/harmful alcohol use are prevalent and correlate with stigma among TB-HIV patients in Lesotho.
    Hayes-Larson E; Hirsch-Moverman Y; Saito S; Frederix K; Pitt B; Maama-Maime L; Howard AA
    Int J Tuberc Lung Dis; 2017 Nov; 21(11):34-41. PubMed ID: 29025483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of short message service and peer navigation to improve engagement in HIV care in South Africa: study protocol for a three-arm cluster randomized controlled trial.
    Lippman SA; Shade SB; Sumitani J; DeKadt J; Gilvydis JM; Ratlhagana MJ; Grignon J; Tumbo J; Gilmore H; Agnew E; Saberi P; Barnhart S; Steward WT
    Trials; 2016 Feb; 17():68. PubMed ID: 26852237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of vitamin D
    Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
    Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count.
    Bigna JJ; Plottel CS; Koulla-Shiro S
    Infect Dis Poverty; 2016 Sep; 5(1):85. PubMed ID: 27593965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved detection and management of advanced HIV disease through a community adult TB-contact tracing intervention with same-day provision of the WHO-recommended package of care including ART initiation in a rural district of Mozambique.
    Izco S; Murias-Closas A; Jordan AM; Greene G; Catorze N; Chiconela H; Garcia JI; Blanco-Arevalo A; Febrer A; Casellas A; Saavedra B; Chiller T; Nhampossa T; Garcia-Basteiro A; Letang E
    J Int AIDS Soc; 2021 Aug; 24(8):e25775. PubMed ID: 34347366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania.
    Geldsetzer P; Francis JM; Ulenga N; Sando D; Lema IA; Mboggo E; Vaikath M; Koda H; Lwezaula S; Hu J; Noor RA; Olofin I; Larson E; Fawzi W; Bärnighausen T
    BMC Health Serv Res; 2017 Feb; 17(1):160. PubMed ID: 28228134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013.
    Nash D; Tymejczyk O; Gadisa T; Kulkarni SG; Hoffman S; Yigzaw M; Elul B; Remien RH; Lahuerta M; Daba S; El Sadr W; Melaku Z
    J Int AIDS Soc; 2016; 19(1):20637. PubMed ID: 27113335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated therapy for HIV and tuberculosis.
    Manosuthi W; Wiboonchutikul S; Sungkanuparph S
    AIDS Res Ther; 2016; 13():22. PubMed ID: 27182275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High rates of viral suppression in a cohort of HIV-positive adults receiving ART in Ethiopian health centers irrespective of concomitant tuberculosis.
    Reepalu A; Balcha TT; Skogmar S; Jemal ZH; Sturegård E; Medstrand P; Björkman P
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19612. PubMed ID: 25394116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What Are the Barriers for Uptake of Antiretroviral Therapy in HIV-Infected Tuberculosis Patients? A Mixed-Methods Study from Ayeyawady Region, Myanmar.
    Aung NHHL; Soe KT; Kumar AMV; Saw S; Aung ST
    Trop Med Infect Dis; 2020 Mar; 5(1):. PubMed ID: 32182967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.